BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FOXP1
,
Fatty acid metabolic process
,
Lung cancer
,
Liver
,
Early pregnancy factor
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
rep 3
Summary
General Info
Curated Studies
Most Correlated Studies
Lung cancer KRAS-mutant A549 cells treated with aurora kinase inhibitors VX680, AZD1152, and MLN8237
Breast cancer MCF7 cells treated with 102 traditional Chinese medicinal components
Primary Rat Hepatocytes treated with TCDD and PCB 126
Hepatic HepaRG cells treated with PCB-126, glyphosate and roundup
iPSC gene expression in response to culture with a small molecule inhibitor cocktail
Explore Curated Studies Results
Literature
Most Relevant Literature
Di-valent siRNA-mediated silencing of MSH3 blocks somatic repeat expansion in mouse models of Huntin…
Identification of disulfidptosis related subtypes, characterization of tumor microenvironment infilt…
SYVN1-mediated ubiquitination and degradation of MSH3 promotes the apoptosis of lens epithelial cell…
Lack of correlation between MSH3 immunohistochemistry and microsatellite analysis for the detection …
Prevalence and Characterization of Biallelic and Monoallelic NTHL1 and MSH3 Variant Carriers From a …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Therapeutic Safety and Efficacy of REP 2139 (REP 9AC') in HBV Infected Patients
Therapeutic Safety and Efficacy of REP 9AC (REP 2055) in HBV or HCV Infected Patients
REP 2139-Mg and REP 2165-Mg Combination Therapy in Chronic Hepatitis B Infection
REP 2139-Ca / Pegasys™ Combination Therapy in Hepatitis B / Hepatitis D Co-infection
Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ